Form S-3 Keros Therapeutics, Inc.

Go back to Form S-3 Keros Therapeutics, Inc.

Keros Therapeutics (KROS) files $350M mixed shelf

September 10, 2026 4:04 PM EDT

Keros Therapeutics (NASDAQ: KROS) filed $350,000,000 mixed shelf of:


Common Stock
Preferred Stock
Debt Securities
Warrants

... More